Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?—a systematic review and meta-analysis

Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?—a systematic review and meta-analysis

Abstract Background Mesenchymal stromal cells (MSCs) are an emerging prophylaxis option for graft-versus-host disease (GVHD) in haplo-identical hematopoietic stem cell transplantation (haplo-HSCT) recipients with severe aplastic anemia (SAA), but studies have reported inconsistent results. This syst...

Full description

Bibliographic Details
Main Authors: Ruonan Li, Jingke Tu, Jingyu Zhao, Hong Pan, Liwei Fang, Jun Shi
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Stem Cell Research & Therapy
Subjects:
Mesenchymal stromal cells
Severe aplastic anemia
Hematopoietic stem cell transplantation
Haplo-identical
Graft-versus-host disease
Meta-analysis
Online Access:https://doi.org/10.1186/s13287-021-02170-7

Internet

https://doi.org/10.1186/s13287-021-02170-7

Similar Items